Panacea Life Sciences Holdings, Inc. (PLSH): Operating Cash Flow
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
-$1.52M
Year ended 2023-12-31
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | -$1.52M | n/m | 2024-04-01, From 2023-01-01 |
| 2022-12-31 | -$2.40M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$3.92M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$7.65M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$5.75M | n/m | 2021-04-23, From 2019-01-01 |
| 2018-12-31 | -$465.8K | n/m | 2020-05-22, From 2018-01-01 |
| 2017-12-31 | -$1.23M | n/m | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | -$891.0K | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | -$640.0K | n/m | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | -$399.6K | n/a | 2016-02-29, From 2014-01-01 |